证券代码：301166 证券简称：优宁维 公告编号：2025-091 上海优宁维生物科技股份有限公司 关于使用闲置自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 上海优宁维生物科技股份有限公司（以下简称"公司"或"优宁维"）于 2025 年 2 月 17 日召开第四届董事会第三次会议和第四届监事会第三次会议，2025 年 3 月 7 日召开 2025 年第二次临时股东大会，审议通过了《关于使用闲置募集资 金及自有资金进行现金管理的议案》，同意公司及并表范围内的子孙公司在不影 响募集资金投资项目建设、不影响公司正常生产经营及确保资金安全的情况下， 使用不超过人民币 30,000 万元（含本数）的闲置募集资金及不超过人民币 150,000 万元（含本数）的自有资金进行现金管理，使用期限自 2025 年 3 月 9 日起 12 个月内有效。公司独立董事和保荐机构均发表了同意意见。具体内容详见公司分 别于 2025 年 2月 19 日和 2025年 3 月 8日刊载于巨潮资讯网（www.cninfo.com.cn） 的相关公告。 现将公 ...

Core Viewpoint - The company You Ning Wei has shown a mixed performance in terms of stock trading and financial results, with a slight increase in stock price but a decline in revenue and net profit for the year-to-date period [1][2]. Group 1: Stock Performance - On November 6, You Ning Wei's stock price increased by 0.71%, with a trading volume of 25.51 million yuan [1]. - The financing buy-in amount on the same day was 2.51 million yuan, while the financing repayment was 2.12 million yuan, resulting in a net financing buy-in of 390,100 yuan [1]. - As of November 6, the total financing and securities lending balance was 58.33 million yuan, accounting for 2.06% of the circulating market value, indicating a relatively high level compared to the past year [1]. Group 2: Financial Performance - For the period from January to September 2025, You Ning Wei reported a revenue of 776 million yuan, representing a year-on-year decrease of 6.24% [2]. - The net profit attributable to the parent company was -15.08 million yuan, reflecting a significant year-on-year decline of 207.11% [2]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for You Ning Wei was 9,893, a decrease of 13.19% from the previous period [2]. - The average number of circulating shares per shareholder increased by 15.19% to 5,753 shares [2]. - The company has distributed a total of 182 million yuan in dividends since its A-share listing, with 138 million yuan distributed over the past three years [3].

Group 1 - The company, You Ning Wei, announced that as of October 31, 2025, it has repurchased a total of 48,300 shares through a dedicated securities account via centralized bidding, which represents 0.06% of the company's total share capital [2]

Core Viewpoint - The company, You Ning Wei (301166.SZ), has announced a share buyback program, indicating a commitment to returning value to shareholders through the repurchase of its own shares [1] Summary by Categories Share Buyback Details - As of October 31, 2025, the company has repurchased a total of 48,300 shares, which represents 0.06% of its total share capital [1] - The highest transaction price for the repurchased shares was 30.89 yuan per share, while the lowest was 30.46 yuan per share [1] - The total amount paid for the repurchase was 1,482,692 yuan, excluding transaction fees [1]

上海优宁维生物科技股份有限公司(以下简称"公司")于 2025 年 4 月 10 日召 开第四届董事会第四次会议、第四届监事会第四次会议，于 2025 年 5 月 13 日召 开 2024 年度股东大会，审议通过了《关于回购公司股份方案的议案》，同意公 司使用不低于人民币 1,500 万元（含本数），不高于人民币 3,000 万元（含本数） 的自有资金以集中竞价交易方式回购公司部分无限售条件的 A 股流通股，用于 注销并减少注册资本，回购价格不超过人民币 44 元/股（含本数，下同），回购 期限自公司 2024 年度股东大会审议通过本次回购股份方案之日起 12 个月内。具 体内容详见公司于 2025 年 4 月 14 日及 2025 年 5 月 13 日刊登在巨潮资讯网的《关 于回购公司股份方案的公告》《回购报告书》。 公司 2024 年度权益分派于 2025 年 5 月 22 日实施完毕，根据《关于回购公 司股份方案的公告》《回购报告书》，公司本次以集中竞价交易方式回购股份价 格上限由不超过人民币 44 元/股调整为不超过人民币 43.77 元/股，回购价格调整 起始日为 2025 年 5 月 22 日（除 ...

Company Overview - Shanghai Youningwei Biotechnology Co., Ltd. was established on October 22, 2004, and listed on December 28, 2021. The company is located at 15 Lane 16, Gudan Road, Pudong New District, Shanghai [1]. - The main business involves providing life science reagents centered on antibodies, related instruments, consumables, and comprehensive technical services to higher education institutions, research institutes, hospitals, and biopharmaceutical companies. The revenue composition is as follows: life science reagents 77.94%, life science instruments and consumables 16.11%, and comprehensive technical services 5.95% [1]. Financial Performance - As of September 30, 2025, the company achieved an operating income of 776 million yuan, a year-on-year decrease of 6.24%. The net profit attributable to the parent company was -15.08 million yuan, a year-on-year decrease of 207.11% [2]. - The company has distributed a total of 182 million yuan in dividends since its A-share listing, with 138 million yuan distributed in the past three years [3]. Stock Performance - On October 31, the stock price increased by 2.04%, reaching 32.00 yuan per share, with a trading volume of 25.75 million yuan and a turnover rate of 1.42%. The total market capitalization is 2.773 billion yuan [1]. - Year-to-date, the stock price has risen by 13.67%, with a 2.24% increase over the last five trading days, a 5.33% increase over the last 20 days, and a 3.53% decrease over the last 60 days [1]. Shareholder Information - As of September 30, 2025, the number of shareholders is 9,893, a decrease of 13.19% from the previous period. The average number of circulating shares per person is 5,753, an increase of 15.19% [2]. - Among the top ten circulating shareholders, the Noan Multi-Strategy Mixed A (320016) fund is the eighth largest shareholder, holding 499,100 shares as a new shareholder [3].

Core Viewpoint - The company reported a decline in revenue and incurred a net loss for the first three quarters of 2025 [1] Financial Performance - The company's operating revenue for the first three quarters was 776 million yuan, representing a year-on-year decrease of 6.24% [1] - The net loss attributable to shareholders of the listed company was 15.08 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 30.27 million yuan [1] - The basic loss per share was 0.17 yuan [1]

Core Viewpoint - The company, You Ning Wei (301166.SZ), reported a decline in revenue and a net loss for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating revenue of 776 million yuan, representing a year-on-year decrease of 6.24% [1] - The net profit attributable to shareholders of the listed company was a loss of 15.08 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of 30.27 million yuan [1] - The basic earnings per share were reported at -0.17 yuan [1]

Company Performance - Youningwei (SZ 301166) reported Q3 performance on October 29, with revenue approximately 776 million yuan, a year-on-year decrease of 6.24% [1] - The net profit attributable to shareholders was a loss of approximately 15.08 million yuan, with basic earnings per share showing a loss of 0.17 yuan [1] - As of the report, Youningwei's market capitalization stands at 2.7 billion yuan [1] Industry Context - The A-share market has surpassed 4000 points, marking a significant resurgence after a decade of stagnation [1] - The technology sector is leading the market's transformation, indicating the emergence of a "slow bull" market pattern [1]

证券代码：301166 证券简称：优宁维 公告编号：2025-089 为真实反映公司截至 2025 年 9 月 30 日的财务状况、资产价值及经营情况， 基于谨慎性原则，依照《会计法》《企业会计准则》等法律、行政法规、部门规 章、规范性文件和《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市 公司规范运作》等相关规定，公司及并表范围内的子孙公司对 2025 年 9 月 30 日各类资产进行了全面清查及评估，对存在减值迹象的相关资产计提相应的减值 准备。 2、本次计提资产减值准备的资产范围、总金额和计入的报告期间 公司及并表范围内的子孙公司对截至 2025 年 9 月 30 日存在可能发生减值迹 象的资产进行全面清查和资产减值测试后，计提 2025 年 1-9 月资产减值准备共 计人民币 9,753,077.02 元，具体明细如下： 上海优宁维生物科技股份有限公司 关于计提资产减值准备的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 上海优宁维生物科技股份有限公司（以下简称"公司"）根据《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司 ...